Regenerative Pharmacology group has its focus on novel drug targets and experimental drugs to reveal the basis of disease modifying therapies of illnesses with unmet medical need, especially degenerative heart and - brain diseases (including drug and alcohol addiction). We explore possibilities of tissue repair by inducing proliferation and differentiation of adult stem cells in the heart and in the brain by chemical and/or protein drugs. Dissolution and imaging of aberrant proteins in the brain relevant to Parkinson’s disease as well as levodopa-induced dyskinesias are in focus. Therapeutic drug targets include transcription factors, protein kinase C (PKC), prolyl oligopeptidase and cell surface receptors such as nicotinic and histaminergic receptors and receptors involved in drug addiction. Unit's principal investigators are listed below.